Chaisaingmongkol et al. studied liver cancer patients in Asia and identified a molecular subtype (C2), characterised by elevated CD4+ memory T cells, reduced Treg cells and higher leucocyte infiltrates, that is associated with good prognosis, suggesting that immunologically “hot” tumours correlated with favourable outcomes [38]. This evidence concerns the gene CD4 and neoplasm.